Hybrid Conferencee

International Symposium on Immunology and Biotechnology (ISIB - 27)

6th - 7th April 2027 | Jelgava, Latvia
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Jelgava. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Jelgava event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Jelgava conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Jelgava, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Jelgava."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Monoclonal Antibody Development

This track will explore the latest innovations in monoclonal antibody technology, including engineering strategies and therapeutic applications. Discussions will focus on the role of monoclonal antibodies in treating various diseases and their impact on patient outcomes.

Track 02

Innovations in Vaccine Development

This session will highlight cutting-edge approaches in vaccine research and development, emphasizing novel platforms and delivery systems. Participants will engage in discussions on the challenges and successes in creating effective vaccines for infectious diseases and cancer.

Track 03

Molecular Immunology: Mechanisms and Applications

This track will delve into the molecular mechanisms underlying immune responses and their implications for disease treatment. Researchers will present findings on signaling pathways, immune cell interactions, and their relevance to therapeutic interventions.

Track 04

Gene Editing Technologies in Immunology

This session will focus on the application of gene editing technologies, such as CRISPR, in the field of immunology. Participants will discuss the potential of these technologies to modify immune responses and develop novel therapies.

Track 05

Cytokine Therapy: Current Trends and Future Directions

This track will examine the therapeutic potential of cytokine modulation in various diseases, including cancer and autoimmune disorders. Researchers will share insights into the challenges of cytokine therapy and strategies for enhancing its efficacy.

Track 06

Immunomodulators: Mechanisms and Therapeutic Applications

This session will explore the role of immunomodulators in regulating immune responses and their applications in clinical settings. Presentations will cover the discovery and development of novel immunomodulatory agents.

Track 07

Translational Research in Immunology

This track will highlight the importance of translational research in bridging the gap between basic immunology and clinical applications. Researchers will present case studies demonstrating successful translation of immunological discoveries into therapeutic strategies.

Track 08

Cellular Immunology: Insights and Innovations

This session will focus on the cellular aspects of the immune system, including T cell and B cell biology. Discussions will encompass recent advancements in cellular therapies and their implications for treating immune-related diseases.

Track 09

Biomarker Discovery in Immunology

This track will address the identification and validation of biomarkers for immune-related diseases, emphasizing their role in diagnostics and personalized medicine. Researchers will share their findings on novel biomarkers and their clinical relevance.

Track 10

Nanotechnology in Immunology and Therapeutics

This session will explore the application of nanotechnology in enhancing immunological research and therapeutic development. Presentations will focus on the design of nanocarriers for targeted drug delivery and their impact on immune responses.

Track 11

Molecular Diagnostics in Immunology

This track will examine the latest advancements in molecular diagnostics for immune-related conditions. Participants will discuss innovative techniques for detecting immune dysfunction and their implications for patient management.